Precision Optics Earnings Call Marks Turnaround Moment

Precision Optics Corporation, Inc. ((POCI)) has held its Q3 earnings call. Read on for the main highlights of the call.

Precision Optics Corporation’s latest earnings call struck an upbeat tone as management highlighted record quarterly revenue, sharply higher gross margins and the company’s first positive adjusted EBITDA in Q3. Executives acknowledged remaining challenges, including yield work on key medical products and an upcoming aerospace slowdown, but framed these as manageable against a backdrop of rising demand, stronger cash reserves and a clearer path toward sustained profitability.

Record Revenue Signals Strong Demand

Precision Optics reported Q3 revenue of $8.7 million, a new quarterly high and more than double the $4.2 million posted a year earlier. Sales also climbed about 18% from the prior quarter’s $7.4 million, underscoring accelerating demand across core aerospace and medical programs.

Adjusted EBITDA Turns Positive

The company delivered a key milestone with adjusted EBITDA turning positive at $300,000 in Q3, compared with a loss of $1.3 million a year ago. This swing from a $1.5 million adjusted EBITDA loss last quarter marks a significant operational inflection as higher volumes and better efficiency start to flow through earnings.

Gross Margins Rebound Sharply

Gross margin jumped to roughly 24% in Q3, up from just 10% a year ago and 2.8% in Q2, lifting gross profit to $2.1 million. Management credited manufacturing improvements and mix benefits for the expansion, positioning margins as a key lever for further earnings gains.

Aerospace Program Drives Growth and Efficiency

Revenue from a top-tier aerospace customer hit a record $3.6 million in Q3, representing 44% sequential growth. Production yields on this program improved to about 97%, up from the typical 85%–95%, highlighting significant manufacturing efficiency gains.

Cystoscope Line Posts Records but Needs Refinement

The single-use cystoscope program generated a record $2.2 million in revenue, around 10% higher than the prior quarter, as demand and output increased. Production yields have risen above 90%, with management targeting 95% in Q4 through ongoing process, tooling and fixture enhancements.

Ross Optical Adds Scale and Margin

Ross Optical contributed $1.3 million of revenue in Q3, up from $0.8 million a year earlier for a 65% year-over-year increase. Management emphasized that this higher-margin business, up from $1.0 million in Q2, should continue to support overall margin expansion as it scales.

Balance Sheet Bolstered by New Capital

The company completed an oversubscribed $10 million public offering, boosting its cash balance to $10.7 million as of March 31, 2026. This compares with roughly $900,000 at the end of December and provides needed working capital for production ramp-ups and strategic investments.

Raised Outlook but Not Yet Profitable Annually

Despite progress, Precision Optics still reported a modest net loss of $108,000 in Q3 and expects full-year adjusted EBITDA to remain negative. The improved guidance, however, narrows the expected loss to a range of $2.5 million to $2.7 million, underscoring a steady march toward break-even on an annual basis.

Tariffs and Credit Memos Affect Reported Sales

The company has negotiated tariff pass-throughs with some customers, which lifted reported revenue to $8.7 million when including these amounts. Management noted that revenue net of tariffs would have been $8.3 million and that issuing tariff refund credit memos will reduce reported sales in those periods, though the bottom-line effect should remain positive.

Facility Footprint and Operational Constraints

Production currently spans three buildings in Gardner, Massachusetts, including some space that has not been modernized, creating operational complexity. Management is assessing facility consolidation and upgrades to better support long-term efficiency, noting that capacity exists but requires optimization.

Customer Concentration and Disclosure Limits

Management reiterated that it cannot name major customers, which limits transparency despite the significance of certain programs such as the leading aerospace client that delivered $3.6 million in Q3 revenue. This concentration heightens risk but also reflects deep relationships with key accounts across aerospace and medical markets.

Guidance and Pipeline Point to Growth

Management raised full-year FY2026 revenue guidance to a range of $29 million to $31 million, up from $26 million to $28 million, implying 52%–62% growth over FY2025’s $19.1 million. With year-to-date revenue at $22.8 million, Q4 needs roughly $6.2 million to $8.2 million, and leadership expects Q4 adjusted EBITDA to be near break-even while 5–6 development programs, including Unity platform efforts, move toward production by FY2027 despite a projected 15%–20% aerospace pullback in early FY2027.

Precision Optics’ earnings call painted a picture of a company transitioning from groundwork to execution, with record revenue, improved margins and positive adjusted EBITDA signaling tangible progress. While customer concentration, yield refinement and facility upgrades remain on the to-do list, the stronger balance sheet and upgraded outlook suggest a constructive path for investors watching the march toward sustainable profitability.